Loading clinical trials...

Study on the Safety and Efficacy of Convalescent Plasma in Patients With Severe COVID-19 Disease | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2NCT04542967

Study on the Safety and Efficacy of Convalescent Plasma in Patients With Severe COVID-19 Disease

Currently, there is no specific treatment or vaccine for SARS-CoV-2 available, some drugs are being investigated as treatment, but the effect is unknown. A strategy and other method used before, in co...

Lead sponsor: Hospital Central Militar•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

TERMINATEDPhase 1/2

RAPA-501-Allo Therapy of COVID-19-ARDS

NCT04482699 · Severe COVID-19 Disease

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 10, 2021Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment150

Start dateJun 2020

Last updatedMay 10, 2021

Condition

Severe COVID-19 Disease

Locations shown

Hospital Central Militar

Mexico City

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 10, 2021Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions